scholarly journals Low Serum Albumin Predicts Severe Outcomes in COVID-19 Infection: A Single-Center Retrospective Case-Control Study

2021 ◽  
Vol 13 (5) ◽  
pp. 258-267
Author(s):  
Roshan Acharya ◽  
Dilli Poudel ◽  
Riley Bowers ◽  
Aakash Patel ◽  
Evan Schultz ◽  
...  
Keyword(s):  
Serum Albumin ◽  
Case Control Study ◽  
Case Control ◽  
Single Center ◽  
Retrospective Case ◽  
Control Study ◽  
Low Serum

Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case–control study

2015 ◽  
Vol 24 (5) ◽  
pp. 2085-2091 ◽  
Author(s):  
Tulay Kus ◽  
Gokmen Aktas ◽  
Gokay Alpak ◽  
Mehmet Emin Kalender ◽  
Alper Sevinc ◽  
...  
Keyword(s):  
Case Control Study ◽  
Case Control ◽  
Single Center ◽  
Retrospective Case ◽  
Acute Neurotoxicity ◽  
Control Study

scholarly journals Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study

2020 ◽  
Author(s):  
Ran Tian ◽  
Wei Wu ◽  
Chunyao Wang ◽  
Haiyu Pang ◽  
Zhiyu Zhang ◽  
...  
Keyword(s):  
Risk Factors ◽  
Large Scale ◽  
Case Control Study ◽  
Case Control ◽  
Hospital Death ◽  
Single Center ◽  
Retrospective Case ◽  
Critical Patients ◽  
Qsofa Score ◽  
Control Study

Abstract Since the outbreak of COVID-19 in China at the end of 2019, the world has experienced a large-scale epidemic caused by the SARS-CoV-2. Epidemiological and clinical course of COVID-19 patients have been reported, but there have been few analyses about the characteristics, predictive risk factors and outcomes of critical patients. In this single-center retrospective case-control study, 90 adult inpatients hospitalized at Tongji Hospital (Wuhan, China) were included. Demographic, clinical, laboratory test and treatment data were obtained and compared between critical and non-critical patients. We found that compared with non-critical patients, the critical patients had higher SOFA score and qSOFA scores. Critical patients had lower lymphocyte and platelet count, elevated D-dimer, decreased fibrinogen, and elevated high-sensitivity C-reactive protein (hsCRP) and interleukin-6(IL-6). More critical patients received treatment including antibiotics, anticoagulation, corticosteroid and oxygen therapy than non-critical ones. Multivariable regression showed higher qSOFA score and elevation of IL-6 were related to critical patients. Antibiotic usage and anticoagulation were associated with decreased in-hospital mortality. And critical grouping contributed greatly to in-hospital death. Critical COVID-19 patients have a more severe clinical cours. qSOFA score and elevation of IL-6 are risk factors for critical condition. Non-critical grouping, positive antibiotic application and anticoagulation may be beneficial for patient survival.

Sign in / Sign up

Export Citation Format

Share Document